ProShare Advisors LLC Purchases 12,952 Shares of Intuitive Surgical, Inc. $ISRG

ProShare Advisors LLC grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the third quarter, HoldingsChannel.com reports. The fund owned 398,808 shares of the medical equipment provider’s stock after buying an additional 12,952 shares during the period. ProShare Advisors LLC’s holdings in Intuitive Surgical were worth $162,167,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of America Corp DE raised its holdings in Intuitive Surgical by 3.3% in the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after buying an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp bought a new stake in Intuitive Surgical during the second quarter worth $1,335,753,000. Amundi grew its stake in shares of Intuitive Surgical by 8.6% during the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after acquiring an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership boosted its position in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the period. Finally, Janus Henderson Group PLC raised its position in shares of Intuitive Surgical by 3.7% during the 1st quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider’s stock valued at $757,489,000 after buying an additional 58,587 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Mark Brosius sold 61 shares of the company’s stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $441.60, for a total transaction of $26,937.60. Following the transaction, the executive vice president owned 581 shares of the company’s stock, valued at $256,569.60. This represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Patricia Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $478,416.40. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 38,778 shares of company stock valued at $16,814,967. Corporate insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several research analyst reports. Leerink Partners set a $503.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a report on Wednesday, October 21st. BTIG Research reaffirmed a “buy” rating and issued a $454.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Oppenheimer restated an “outperform” rating and issued a $500.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, HSBC lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $432.01 on Friday. The stock has a market capitalization of $149.75 billion, a P/E ratio of 52.24, a P/E/G ratio of 2.98 and a beta of 1.46. The company’s 50-day simple moving average is $401.54 and its 200-day simple moving average is $434.05. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to analyst estimates of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. Intuitive Surgical’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the business earned $2.40 EPS. On average, research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.